# Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa

> **NCT01448187** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 361 (actual)

## Conditions studied

- Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01448187
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 361 (ACTUAL)
- **Last updated:** 2016-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448187, "Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01448187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*